Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation

[1]  H. Lassmann,et al.  Explorer NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury , 2012 .

[2]  H. Lassmann,et al.  The molecular basis of neurodegeneration in multiple sclerosis , 2011, FEBS letters.

[3]  X. Montalban,et al.  Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: An ongoing story , 2011, Journal of Neuroimmunology.

[4]  H. D. de Vries,et al.  Radical changes in multiple sclerosis pathogenesis. , 2011, Biochimica et biophysica acta.

[5]  J. Geurts,et al.  Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies. , 2011, CNS & neurological disorders drug targets.

[6]  Helga E de Vries,et al.  Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? , 2010, Mitochondrion.

[7]  Daniela Prayer,et al.  Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 Tesla , 2010, PloS one.

[8]  L. Steinman,et al.  &agr;B-Crystallin Is a Target for Adaptive Immune Responses and a Trigger of Innate Responses in Preactive Multiple Sclerosis Lesions , 2010, Journal of neuropathology and experimental neurology.

[9]  P. Stys,et al.  Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. , 2010, Trends in molecular medicine.

[10]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[11]  S. Nataf.  Neuroinflammation responses and neurodegeneration in multiple sclerosis. , 2009, Revue neurologique.

[12]  J. Geurts,et al.  Enhanced number and activity of mitochondria in multiple sclerosis lesions , 2009, The Journal of pathology.

[13]  W. Brück,et al.  Molecular Changes in White Matter Adjacent to an Active Demyelinating Lesion in Early Multiple Sclerosis , 2009, Brain pathology.

[14]  S. Amor,et al.  Preactive lesions in multiple sclerosis , 2009, Current opinion in neurology.

[15]  R. Gold,et al.  Function of neurotrophic factors beyond the nervous system: inflammation and autoimmune demyelination. , 2009, Critical reviews in immunology.

[16]  P. Calabresi,et al.  A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis , 2008, Brain : a journal of neurology.

[17]  B. Trapp,et al.  Multiple sclerosis: an immune or neurodegenerative disorder? , 2008, Annual review of neuroscience.

[18]  Hans Lassmann,et al.  Mitochondrial defects in acute multiple sclerosis lesions , 2008, Brain : a journal of neurology.

[19]  R. Reynolds,et al.  Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. , 2007, Brain : a journal of neurology.

[20]  H. Lassmann,et al.  Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? , 2007, Brain : a journal of neurology.

[21]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[22]  L. Bö,et al.  NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions. , 2006, Free radical biology & medicine.

[23]  L. Rasmussen,et al.  Targeting of O6-MeG DNA methyltransferase (MGMT) to mitochondria protects against alkylation induced cell death. , 2005, Mitochondrion.

[24]  C. Teunissen,et al.  Macrophages and neurodegeneration , 2005, Brain Research Reviews.

[25]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[26]  R. Reynolds,et al.  Molecular Changes in Normal Appearing White Matter in Multiple Sclerosis are Characteristic of Neuroprotective Mechanisms Against Hypoxic Insult , 2003, Brain pathology.

[27]  B. Trapp,et al.  Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients , 2003, Journal of neuropathology and experimental neurology.

[28]  R. Kinkel,et al.  Axonal loss in normal-appearing white matter in a patient with acute MS , 2001, Neurology.

[29]  F Barkhof,et al.  Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. , 2001, Brain : a journal of neurology.

[30]  I. V. Allen,et al.  Pathological abnormalities in the normal-appearing white matter in multiple sclerosis , 2001, Neurological Sciences.

[31]  C. D. DE GROOT,et al.  Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS , 2000, Neuropathology and applied neurobiology.

[32]  M. Esiri,et al.  The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. , 1997, Brain : a journal of neurology.

[33]  H. Lassmann,et al.  Histopathology and the blood–cerebrospinal fluid barrier in multiple sclerosis , 1994, Annals of neurology.

[34]  A. Verhoeven,et al.  Characterization of two monoclonal antibodies against cytochrome b558 of human neutrophils. , 1989, Blood.

[35]  M. Duchowny,et al.  Cytomegalovirus infection of the adult nervous system , 1979, Annals of neurology.